Nalaganje...
Establishment of a neuroendocrine prostate cancer model driven by the RNA splicing factor SRRM4
Neuroendocrine prostate cancer (NEPC) is becoming more prevalent as more potent androgen receptor (AR) pathway inhibitors are applied to patients with metastatic tumors. However, there are limited cell and xenograft models currently available, hindering the investigation of signal pathways involved...
Shranjeno v:
| izdano v: | Oncotarget |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Impact Journals LLC
2017
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5620142/ https://ncbi.nlm.nih.gov/pubmed/28978002 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.19916 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|